Mesotherapy Position Statement
The American Society for Aesthetic Plastic Surgery (ASAPS) recently issued a "position paper" on the use of mesotherapy. A position paper by an organization such as the ASAPS presents the organization's official stance on a technique like mesotherapy or a device like a new laser. In this way, a plastic surgeon can better form an objective opinion on a new technique or device without listening to biased individuals like the inventor of the technique or the manufacturer of the device.
The ASAPS often forms ad hoc committees specifically to address new techniques like mesotherapy, where the public is inundated with non-scientific information from the media. Because of this media blitz, plastic surgeons are asked about mesotherapy by their patients. The Aesthetic Society Mesotherapy Committee scours the world literature for any and all information on mesotherapy. Is it safe? Is it effective? What exactly is it? Should plastic surgeons consider doing mesotherapy in their practices? How do they learn how do perform mesotherapy? These are all questions that organizations like the ASAPS want to answer through their ad hoc mesotherapy committee.
Here are the recommendations that the ASAPS made to its members, after an extensive investigation into the use of mesotherapy:
ASAPS does not endorse the injection of phosphatydal choline, deocycholate or any other drugs, vitamins, plant extracts, hormones, etc. into subcutaneous fat as practiced in mesotherapy/Lipodissolve treatments. At present, these therapies lack objective proof of safety and efficacy. They also lack FDA approval.
Members should therefore refrain from adopting these procedures until the results of the ASERF [a plastic surgery research organization] study are available to provide proof of safety and efficacy, or lack thereof. If and when patients ask about these treatments, the scientific reality that currently exists should be explained to them, along with the caution to wait until something definitive is known. Until then, patients should be warned about seeking treatments from people who may not be qualified to administer large numbers of injections that require very precise placement.
[Reprinted from the SPRING 2006 issue of Aesthetic Society News, Volume 10, Number 2.]
The ASAPS often forms ad hoc committees specifically to address new techniques like mesotherapy, where the public is inundated with non-scientific information from the media. Because of this media blitz, plastic surgeons are asked about mesotherapy by their patients. The Aesthetic Society Mesotherapy Committee scours the world literature for any and all information on mesotherapy. Is it safe? Is it effective? What exactly is it? Should plastic surgeons consider doing mesotherapy in their practices? How do they learn how do perform mesotherapy? These are all questions that organizations like the ASAPS want to answer through their ad hoc mesotherapy committee.
Here are the recommendations that the ASAPS made to its members, after an extensive investigation into the use of mesotherapy:
ASAPS does not endorse the injection of phosphatydal choline, deocycholate or any other drugs, vitamins, plant extracts, hormones, etc. into subcutaneous fat as practiced in mesotherapy/Lipodissolve treatments. At present, these therapies lack objective proof of safety and efficacy. They also lack FDA approval.
Members should therefore refrain from adopting these procedures until the results of the ASERF [a plastic surgery research organization] study are available to provide proof of safety and efficacy, or lack thereof. If and when patients ask about these treatments, the scientific reality that currently exists should be explained to them, along with the caution to wait until something definitive is known. Until then, patients should be warned about seeking treatments from people who may not be qualified to administer large numbers of injections that require very precise placement.
[Reprinted from the SPRING 2006 issue of Aesthetic Society News, Volume 10, Number 2.]
posted by Dr. Frank Ryan | 8:28 AM
0 Comments:
Post a Comment
<< Home